369
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints

, , , &
Pages 945-949 | Received 01 Oct 2016, Accepted 24 May 2017, Published online: 12 Jun 2017

References

  • Chou AH, Liu CC, Chang JY, et al. Immunological evaluation and comparison of different EV71 vaccine candidates. Clin Dev Immunol. 2012;(2012(3):831282.
  • Lee MS, Chang LY. Development of enterovirus 71 vaccines. Expert Rev Vaccines. 2010;9(2):149–156.
  • Kung YA, Hung CT, Liu YC, et al. Update on the development of enterovirus 71 vaccines. Expert Opin Biol Ther. 2014;14(10):1455–1464.
  • Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine. 2000;18(18 Suppl 2):26–32.
  • Jin P, Li J, Zhang X, et al. Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months. Hum Vaccin Immunother. 2016;12(4):916–921.
  • Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381(9882):2024–2032.
  • Dunning AJ. A model for immunological correlates of protection. Stat Med. 2006;25(9):1485–1497.
  • Dunning AJ, Kensler J, Coudeville L, et al.Some extensions in continuous models for immunological correlates of protection. BMC Med Res Methodol. 2015;15:107–118.
  • Wei M, Meng F, Wang S, et al. Two-year efficacy, immunogenicity, and safety of Vigoo Enterovirus 71 vaccine in healthy Chinese children: a randomised open-label study. J Infect Dis. 2017;215(1):56–63.
  • Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med. 1989;8(4):431–440.
  • Sadoff JC, Wittes J. Correlates, surrogates, and vaccines. J Infect Dis. 2007;196(9):1279–1281.
  • Zhu F-C, Liang Z-L, Li X-L, et al. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet. 2013;381(9871):1037–1045.
  • Lin TY, Twu SJ, Ho MS, et al. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis. 2003;9(3):291–293.
  • Chen X, Bailleux F, Desai K, et al. A threshold method for immunological correlates of protection. BMC Med Res Methodol. 2013;13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.